You need to be logged in to view this video
Biotech Stocks You May Have Overlooked: Highlight Cannabis Stocks That Will Improve the Way We Live
Released on Wednesday, March 30, 2016•CANNABIS
Earlier this month, GW Pharmaceuticals reshaped the way many people view cannabis when the company reported positive Stage 3 Clinical data for its Epidiolex product. For thousands of years, people all over the world used cannabis for a medicine. During this topic, Michael Berger, President of Technical420.com, will discuss how cannabis could shake up the pharmaceutical industry through the development of less harmful treatments for various illnesses.
Michael Berger
Technical420.com,
President & Founder
Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Technical420.com. Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.
Trending Now
Filter By Category
Filter By Keywords
Loading...